Good Response to COVID-19 Vaccine After HSCT and CAR T-cell Tx

A small study shows relatively good responses among patients with blood cancers who underwent allogeneic hematopoeitic stem cells transplant (HSCT) and CAR T-cell therapy.
Medscape Medical News